Work

Epacadostat plus pembrolizumab in patients with advanced melanoma: Phase 1 and 2 efficacy and safety results from ECHO-202/KEYNOTE-037

Year: 2017

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx377.001

Authors: O. Hamid, T.F. Gajewski, A.E. Frankel, T.M. Bauer, A.J. Olszanski, J.J. Luke, A.S. Balmanoukian, E.V. Schmidt, B. Sharkey, J. Maleski, M.J. Jones, T.C. Gangadhar

Institutions: Angeles Clinic and Research Institute, University of Chicago, The University of Texas Southwestern Medical Center, Sarah Cannon, Tennessee Oncology, Fox Chase Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States), Incyte (United States), Abramson Cancer Center, University of Pennsylvania

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2764138596

FWCI: 3.877

Cites:

Cited by: 48

Related to: 10